Savera Industries Ltd

Savera Industries Ltd

₹ 149 -0.60%
29 May - close price
About

Incorporated in 1969, Savera Industries Ltd
is in the Hotel business.[1]

Key Points

Business Overview:[1][2]
SIL manages a 4-star hotel, Hotel Savera, in Chennai and seven health centres under the O2 Health brand. The hotel is equipped
with modern amenities such as a swimming pool, banquet halls, and ample car parking space. On December 18th, 2024, the company entered into a new line of business of a packaged drinking water manufacturing plant as a part of expansion on the leased property consisting of land and building from a related party, M/s. Shyam Hotels & Restaurants.

  • Market Cap 178 Cr.
  • Current Price 149
  • High / Low 189 / 133
  • Stock P/E 16.0
  • Book Value 81.4
  • Dividend Yield 2.01 %
  • ROCE 15.0 %
  • ROE 12.0 %
  • Face Value 10.0

Pros

  • Company is almost debt free.
  • Company is expected to give good quarter
  • Promoter holding has increased by 1.82% over last quarter.

Cons

  • Company has a low return on equity of 13.1% over last 3 years.
  • Earnings include an other income of Rs.6.15 Cr.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
16.25 17.35 18.34 17.47 18.99 17.93 20.60 19.29 21.83 22.08 25.50 27.17 27.58
12.47 13.67 14.24 14.24 16.81 15.30 14.99 16.59 17.91 17.56 19.61 22.67 24.78
Operating Profit 3.78 3.68 4.10 3.23 2.18 2.63 5.61 2.70 3.92 4.52 5.89 4.50 2.80
OPM % 23.26% 21.21% 22.36% 18.49% 11.48% 14.67% 27.23% 14.00% 17.96% 20.47% 23.10% 16.56% 10.15%
0.64 0.63 0.47 1.10 0.85 1.64 1.12 0.87 0.95 3.29 1.13 1.12 0.61
Interest 0.07 0.05 0.09 0.10 0.09 0.08 0.10 0.16 0.12 0.15 0.19 0.22 0.20
Depreciation 0.69 0.64 0.54 0.68 0.68 0.60 0.60 0.71 0.82 0.98 1.87 1.94 1.94
Profit before tax 3.66 3.62 3.94 3.55 2.26 3.59 6.03 2.70 3.93 6.68 4.96 3.46 1.27
Tax % 26.78% 25.69% 23.60% 23.66% 15.93% 25.63% 21.39% 25.19% 3.05% 13.92% 27.62% 19.94% 45.67%
2.69 2.69 3.01 2.70 1.90 2.67 4.74 2.02 3.81 5.75 3.60 2.77 0.70
EPS in Rs 2.26 2.26 2.52 2.26 1.59 2.24 3.97 1.69 3.19 4.82 3.02 2.32 0.59
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
62 66 68 72 72 67 20 32 61 72 80 102
51 54 56 60 59 56 21 30 47 59 65 85
Operating Profit 12 12 13 12 13 11 -1 2 14 13 15 18
OPM % 18% 18% 18% 17% 18% 16% -5% 5% 23% 18% 19% 17%
1 1 -1 -0 1 0 1 1 4 3 5 6
Interest 3 3 2 1 1 1 0 0 0 0 0 1
Depreciation 5 4 4 4 3 5 4 3 3 3 3 7
Profit before tax 4 6 5 7 9 6 -5 -1 15 13 16 16
Tax % 27% 58% 41% 24% 32% 27% -10% 14% 19% 23% 18% 22%
3 2 3 5 6 4 -4 -1 12 10 13 13
EPS in Rs 2.42 2.04 2.63 4.30 5.26 3.59 -3.44 -0.67 10.45 8.64 11.10 10.75
Dividend Payout % 50% 74% 57% 58% 23% 33% 0% 0% 29% 35% 27% 0%
Compounded Sales Growth
10 Years: 4%
5 Years: 39%
3 Years: 19%
TTM: 28%
Compounded Profit Growth
10 Years: 16%
5 Years: 38%
3 Years: 3%
TTM: -7%
Stock Price CAGR
10 Years: 9%
5 Years: 27%
3 Years: 28%
1 Year: 2%
Return on Equity
10 Years: 9%
5 Years: 11%
3 Years: 13%
Last Year: 12%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 12 12 12 12 12 12 12 12 12 12 12 12
Reserves 39 39 42 44 47 49 46 46 59 66 76 85
23 18 13 7 3 3 5 2 4 4 6 7
12 13 12 12 11 9 6 7 8 14 12 13
Total Liabilities 86 82 79 75 73 73 69 67 83 95 106 118
67 66 65 61 59 59 55 52 46 42 45 44
CWIP 0 0 0 0 0 0 0 0 0 0 0 0
Investments 3 0 2 2 2 2 2 3 13 15 18 31
15 15 12 11 11 13 11 11 24 39 43 42
Total Assets 86 82 79 75 73 73 69 67 83 95 106 118

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
13 16 10 11 9 10 -4 4 12 8 13 14
-4 -5 -3 -0 -2 -3 1 -2 -13 -1 -10 -3
-8 -11 -7 -11 -7 -6 -1 -1 0 -4 -6 -7
Net Cash Flow 1 -0 -0 -0 0 1 -4 2 -0 3 -3 4
Free Cash Flow 12 12 5 10 8 9 -4 4 20 6 13 16
CFO/OP 129% 147% 107% 118% 100% 108% 332% 313% 109% 82% 109% 100%

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 7 11 14 11 7 6 12 8 7 8 8 9
Inventory Days 5 7 6 8 26 13 12 6 8 11
Days Payable 59 44 40 38 110 54 34 68 62 43
Cash Conversion Cycle -47 -27 14 11 -26 -24 -72 -34 -15 -54 -46 -22
Working Capital Days -82 -68 -58 -41 -27 -25 -104 -59 -38 -44 -52 -41
ROCE % 10% 12% 13% 14% 16% 11% -6% -0% 19% 17% 17% 15%

Insights

In beta
Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Room Occupancy
%

Log in to view insights

Please log in to see hidden values.

Login
Guest Covers
Numbers
Number of Health Centres (O2 Health Brand)
Centres
Number of Rooms
Rooms
Employee Attrition Rate
%
Electricity Consumption via Renewable Sources
Lakh Units

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

16 Recently
Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
62.80% 62.80% 62.80% 62.80% 62.81% 62.81% 62.81% 62.81% 62.81% 62.81% 62.81% 64.62%
0.00% 0.00% 0.00% 0.88% 0.52% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
37.19% 37.20% 37.20% 36.31% 36.66% 37.20% 37.19% 37.21% 37.20% 37.20% 37.21% 35.38%
No. of Shareholders 5,0055,0155,4826,6796,6756,0596,1365,9565,8365,8475,6745,443

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents